HUNDREDS of thousands more Brits could be offered weight loss jabs on the NHS in the biggest shake up of diabetes care in a decade – as the health service prepares to ease rules around ...

The NHS should move away from a one-size-fits-all approach of starting everyone on the same medication, according to new ...

Columnist Teri Sforza writes that studies have found that the popular weight-loss and diabetes drugs reduced alcohol intake, ...

Columnist Teri Sforza writes that studies have found that the popular weight-loss and diabetes drug reduced alcohol intake, ...

New draft guidance from the National Institute for Health and Care Excellence suggests the NHS should move away from a ...

Columnist Teri Sforza writes that studies have found that semaglutide reduced alcohol intake, binge drinking and relapse ...

According to Google Canada, Quebec City is the first municipality in the country to partner with the web giant's Green Light ...

TORONTO - Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes.

In recent years, weight loss medications have gained significant attention, particularly as alternatives to established drugs like Ozempic and other GLP-1 receptor agonists. However, new research has ...

GLP-1 receptor agonists, including semaglutide and tirzepatide, are commonly prescribed to aid weight loss and manage type 2 diabetes. While these drugs have been effective for many patients, recent ...

You do not need to avoid alcohol while taking Ozempic. However, using them together may increase the risk of certain side ...

More than 15 million Americans are now losing weight with GLP-1 drugs. The medications — drugs like Ozempic, Wegovy and Mounjaro that were originally created to treat type 2 diabetes — have been shown ...